Lv3
400 积分 2023-06-24 加入
Improving In Vitro–In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules
1天前
求助中
Improving In Vitro–In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules
2天前
已关闭
Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase Inhibitors
5天前
已完结
Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects
10天前
已完结
Clinical Pharmacokinetics of Atorvastatin
10天前
已完结
Drug Design and Success of Prospective Mouse In Vitro–In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CLp) from Hepatocyte Intrinsic Clearance (CLint)
21天前
已完结
CYP3A Time-Dependent Inhibition Risk Assessment Validated with 400 Reference Drugs
1个月前
已完结
Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
1个月前
已完结
Prediction of in Vivo Nonlinear First-Pass Hepatic Metabolism of YM796 from in Vitro Metabolic Data
1个月前
已完结
Discovery of FHD-286, a First-in-Class, Orally Bioavailable, Allosteric Dual Inhibitor of the Brahma Homologue (BRM) and Brahma-Related Gene 1 (BRG1) ATPase Activity for the Treatment of SWItch/Sucrose Non-Fermentable (SWI/SNF) Dependent Cancers
1个月前
已完结
皖公网安备34019202002308
